Radiology Doctors in Maple Grove, MN Accepting Medicare

3 Radiology doctors found. Showing 1 - 3

Joanna Arcuni Carlson, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 17585 75th Ave N, Maple Grove, MN 55311 Phone: 952-595-1100    Fax: 612-294-4903

Juan Jose Roig, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 17757 71st Avenue North, Maple Grove, MN 55311 Phone: 763-420-8728

Dr. Jeannette Louise Wilcox, MD Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1000

News Archive

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small cell lung cancers (NSCLC).

Insurer's "triple-barreled assault" triggers counter attacks

A "triple-barreled" insurance industry attack on the Senate Finance Committee's health legislation - including separate reports sponsored by America's Health Insurance Plans and the Blue Cross and Blue Shield Association, as well as television advertisements in six states - is "a reminder that the insurance industry has enormous financial stakes in a health care overhaul and will not sit by while its interests are threatened," the New York Times reports (Seelye, 10/14).

Philips and Bruker sign MOU to develop new imaging technology

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation, today announced that they have signed a memorandum of understanding (MOU) for the development of Magnetic Particle Imaging (MPI) scanners, a new imaging technology, for the preclinical market.

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

A Phase III trial of a drug used for the treatment of vitreomacular adhesion and macular hole revealed key findings for patients diagnosed with these severe conditions which can lead to significant vision impairment.

Read more Medical News

› Verified 5 days ago